Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/00207578.2021.1970317 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Gender-Affirming Hormone Treatment and Metabolic Syndrome Among Transgender Veterans.
JAMA Netw Open
July 2024
Human Genetics, David Geffen School of Medicine, University of California, Los Angeles.
Article Synopsis
- Gender-affirming hormone treatment (GAHT) is used by transgender individuals to alleviate gender dysphoria and enhance life quality, but more research is needed on its long-term effects.* -
- This study aimed to determine the relationship between sex hormones (estradiol for transfeminine individuals and testosterone for transmasculine individuals) and the development of metabolic syndrome in transgender veterans compared to cisgender veterans.* -
- The research involved a cohort of 1,290 participants and found that changes in metabolic syndrome risk scores over time varied significantly between transgender individuals and cisgender referents.*
Neurologic Care for Transgender and Gender-Diverse People: A Review of Current Evidence and Clinical Implications.
Neurol Clin Pract
October 2024
Department of Neurology (GZ), Albany Medical College, NY; Department of Neurology (CAH), The Ohio State University College of Medicine, Columbus; Department of Neurology and Weill Institute for Neurosciences (NR), University of California San Francisco; Movement Disorder Clinic (CG), Edmond J. Safra Program in Parkinson's Disease, Division of Neurology, University of Toronto, Toronto Western Hospital, Ontario, Canada; Facultad de Medicina Alberto Hurtado (VR), Universidad Peruana Cayetano Heredia, Lima, Peru; Department of Neurology (AP), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Neurology (SA-L), University of Texas Southwestern Medical Center, Dallas; Department of Pediatric Neurology (CO-P), University of California, Los Angeles; Department of Neurology (WD), UMass Memorial Medical Center and UMass Medical School, Worcester; The Ohio State University Wexner Medical Center (MLH), Columbus; Greenburgh Pride (ZPLE), Westchester, NY.
Article Synopsis
- * Research shows TGD individuals experience a higher rate of neurologic conditions, such as migraines and sleep disturbances, compared to the cisgender population, along with unique risks related to hormone therapy and certain surgeries.
- * Neurologists are encouraged to integrate the specific health needs and experiences of TGD patients into their care approaches and research initiatives.
Gender-affirming surgeries for transgender and gender diverse individuals and associated health outcomes.
Behav Sci Law
October 2024
Department of Plastic and Oral Surgery, Boston Children's Hospital, Boston, Massachusetts, USA.
Gender-affirming care is treatment that recognizes and affirms the gender identity of transgender and gender-diverse (TGD) individuals. Though not all TGD people choose to surgically transition, gender-affirming surgeries (GAS) are an important part of many TGD people's transition. GAS can include a wide array of procedures aimed at aligning an individual's physical characteristics and gender identity.
View Article and Find Full Text PDFHepatitis C Virus Testing and Care Cascade Among Transgender and Gender Diverse Individuals.
Am J Prev Med
May 2023
Department of Health Behavior & Health Education, School of Public Health, University of Michigan, Ann Arbor, Michigan; Institute for Social Research, University of Michigan, Ann Arbor, Michigan.
Introduction: Hepatitis C virus (HCV) prevalence among transgender and gender-diverse individuals ranges from 1.8% to 15.7% versus 1% in the general population.
View Article and Find Full Text PDFVariability in eating disorder risk and diagnosis in transgender and gender diverse college students.
Ann Epidemiol
June 2022
Department of Psychiatry and Behavioral Sciences, University of Minnesota Medical School, Minneapolis, MN.
Purpose: To examine differences in elevated eating disorder risk and self-reported eating disorder diagnosis across subgroups of transgender and gender diverse (TGD) college students.
Methods: Data from 5057 TGD college students participating in the national Healthy Minds Study between 2014 and 2019 were analyzed. Chi-square tests and logistic regression analyses examined heterogeneity in prevalence and odds of elevated eating disorder risk, as measured by the SCOFF, and self-reported eating disorder diagnosis by gender, as well as by intersecting gender and sexual orientation identities.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!